NEW YORK, NY / ACCESS Newswire / March 25, 2025 / If you suffered a loss on your Zynex, Inc. (NASDAQ:ZYXI) investment and want to learn about a ...
Law Offices of Howard G. Smith reminds investors of the upcoming May 19, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Zynex, Inc. ("Zynex" or ...
1d
TipRanks on MSNShareholders of Zynex, Inc. Should Contact Levi & Korsinsky LLP Before May 19, 2025 to Discuss Your Rights – ZYXIA class action securities lawsuit was filed against Zynex, Inc. (ZYXI) that seeks to recover losses of Zynex, Inc. shareholders who ...
Glancy Prongay & Murray LLP reminds investors of the upcoming May 19, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired ...
NEW YORK CITY, NY / ACCESS Newswire / March 21, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
Zynex specializes in non-invasive pain management and patient monitoring, with promising advancements. Read why I think ZYXI ...
The litigation is focused on the propriety of Zynex's statements about its sales and billing practices, its revenue recognition practices, and its relationship with the military health program for ...
Zynex, Inc., et al., Case No. 25-cv-00913, on behalf of persons and entities that purchased or otherwise acquired Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI) securities between ...
Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Zynex, Inc. (NASDAQ: ZYXI) securities between March 13, 2023 to ...
13d
Fintel on MSNLadenburg Thalmann Downgrades Zynex (ZYXI)Fintel reports that on March 12, 2025, Ladenburg Thalmann downgraded their outlook for Zynex (NasdaqGS:ZYXI) from Buy to ...
Despite a net loss and TRICARE payment suspension, Zynex Inc (ZYXI) shows resilience with revenue growth and strategic ...
Zynex (NASDAQ:ZYXI – Get Free Report) had its price objective lowered by equities researchers at HC Wainwright from $17.00 to $15.00 in a research note issued on Wednesday,Benzinga reports. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results